TGF-β and osteoarthritis

Osteoarthritis and Cartilage

Volumn 15, Issue 6, 2007, Pages 597-604

  Blaney Davidson, E N ^a   van der Kraan, P M ^a   van den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BMP 2; Cartilage; CTGF; Fibrosis; Osteoarthritis; Osteophytes; TGF

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOGLYCAN; SMAD PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

CARTILAGE CELL; CHONDROPATHY; COMBINATION CHEMOTHERAPY; FIBROSIS; GENE TRANSFER; HUMAN; MEDLINE; MONOTHERAPY; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; OSTEOPOROSIS; PEER REVIEW; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; CARTILAGE, ARTICULAR; FEMALE; HUMANS; MALE; MICE; OSTEOARTHRITIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 34248561110     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.02.005     Document Type: Review

References (101)

1. Kuettner K.E., and Cole A.A. Cartilage degeneration in different human joints. Osteoarthritis Cartilage 13 2 (2005 Feb) 93-103
2. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14 1 (2006 Jan) 13-29
3. Dingle J.T. Catabolin-a cartilage catabolic factor from synovium. Clin Orthop 156 (1981 May) 219-231
4. Pujol J.P., and Loyau G. Interleukin-1 and osteoarthritis. Life Sci 41 10 (1987 Sep 7) 1187-1198
5. Westacott C.I., and Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction?. Semin Arthritis Rheum 25 4 (1996 Feb) 254-272
6. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 12 Suppl A (2004) S31-S33
7. Vuolteenaho K., Moilanen T., Jalonen U., Lahti A., Nieminen R., van Beuningen H.M., et al. TGFbeta inhibits IL-1 -induced iNOS expression and NO production in immortalized chondrocytes. Inflamm Res 54 10 (2005 Oct) 420-427
8. Pasternak R.D., Hubbs S.J., Caccese R.G., Marks R.L., Conaty J.M., and DiPasquale G. Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes. Clin Immunol Immunopathol 41 3 (1986 Dec) 351-367
9. Takahashi N., Rieneck K., van der Kraan P.M., van Beuningen H.M., Vitters E.L., Bendtzen K., et al. Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthritis Cartilage 13 5 (2005 May) 426-438
10. Bocquet J., Daireaux M., Langris M., Jouis V., Pujol J.P., Beliard R., et al. Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes. Biochem Biophys Res Commun 134 2 (1986 Jan 29) 539-549
11. Goldring M.B., Birkhead J.R., Suen L.F., Yamin R., Mizuno S., Glowacki J., et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest 94 6 (1994 Dec) 2307-2316
12. Bhatnagar R., Penfornis H., Mauviel A., Loyau G., Saklatvala J., and Pujol J.P. Interleukin-1 inhibits the synthesis of collagen by fibroblasts. Biochem Int 13 4 (1986 Oct) 709-720
13. Hubbard J.R., Steinberg J.J., Bednar M.S., and Sledge C.B. Effect of purified human interleukin-1 on cartilage degradation. J Orthop Res 6 2 (1988) 180-187
14. O'Byrne E.M., Schroder H.C., Stefano C., and Goldberg R.L. Catabolin/interleukin-1 regulation of cartilage and chondrocyte metabolism. Agents Actions 21 3-4 (1987 Aug) 341-344
15. Pujol J.P., Galera P., Redini F., Mauviel A., and Loyau G. Role of cytokines in osteoarthritis: comparative effects of interleukin 1 and transforming growth factor-beta on cultured rabbit articular chondrocytes. J Rheumatol Suppl 27 (1991 Feb) 76-79
16. Redini F., Galera P., Mauviel A., Loyau G., and Pujol J.P. Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett 234 (1988) 172-176
17. Redini F., Daireaux M., Mauviel A., Galera P., Loyau G., and Pujol J.P. Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-beta (TGF-beta). Biochim Biophys Acta 1093 2-3 (1991 Jul 10) 196-206
18. Tyler J.A. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 260 2 (1989 Jun 1) 543-548
19. Goldring S.R., and Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop 427 Suppl (2004 Oct) S27-S36
20. van der Kraan P.M., Glansbeek H.L., Vitters E.L., and van den Berg W.B. Early elevation of transforming growth factor-beta, decorin, and biglycan mRNA levels during cartilage matrix restoration after mild proteoglycan depletion. J Rheumatol 24 3 (1997) 543-549
21. Wang J., Verdonk P., Elewaut D., Veys E.M., and Verbruggen G. Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro. Osteoarthritis Cartilage 11 11 (2003 Nov) 801-809
22. Martel-Pelletier J., McCollum R., DiBattista J., Faure M.P., Chin J.A., Fournier S., et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 35 5 (1992 May) 530-540
23. Shlopov B.V., Gumanovskaya M.L., and Hasty K.A. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum 43 1 (2000 Jan) 195-205
24. Blaney Davidson E.N., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Expression of TGF-beta and the TGF-beta signaling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis Role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis (2006 Jan 26)
25. Blaney Davidson E.N., Scharstuhl A., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity. Arthritis Res Ther 7 6 (2005) R1338-R1347
26. Redini F., Mauviel A., Pronost S., Loyau G., and Pujol J.P. Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 36 1 (1993 Jan) 44-50
27. Chandrasekhar S., and Harvey A.K. Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 157 (1988) 1352-1359
28. de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 15 1 (2004 Feb) 1-11
29. Javelaud D., and Mauviel A. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. Int J Biochem Cell Biol 36 7 (2004 Jul) 1161-1165
30. Roberts A.B. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24 2-3 (1998) 111-119
31. Jobling A.I., Nguyen M., Gentle A., and McBrien N.A. Isoform-specific changes in scleral transforming growth factor-beta expression and the regulation of collagen synthesis during myopia progression. J Biol Chem 279 18 (2004 Apr 30) 18121-18126
32. Govinden R., and Bhoola K.D. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 98 2 (2003 May) 257-265
33. Lawrence D.A. Latent-TGF-beta: an overview. Mol Cell Biochem 219 1-2 (2001 Mar) 163-170
34. Todorovic V., Jurukovski V., Chen Y., Fontana L., Dabovic B., and Rifkin D.B. Latent TGF-beta binding proteins. Int J Biochem Cell Biol 37 1 (2005 Jan) 38-41
35. Roberts A.B. TGF-beta signaling from receptors to the nucleus. Microbes Infect 1 15 (1999 Dec) 1265-1273
36. Verrecchia F., and Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118 2 (2002 Feb) 211-215
37. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 6958 (2003 Oct 9) 577-584
38. Javelaud D., and Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24 37 (2005 Aug 29) 5742-5750
39. Yamada Y., Okuizumi H., Miyauchi A., Takagi Y., Ikeda K., and Harada A. Association of transforming growth factor beta 1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 43 2 (2000 Feb) 452-460
40. Kamiya M., Harada A., Mizuno M., Iwata H., and Yamada Y. Association between a polymorphism of the transforming growth factor-beta1 gene and genetic susceptibility to ossification of the posterior longitudinal ligament in Japanese patients. Spine 26 11 (2001 Jun 1) 1264-1266
41. Lau H.H., Ho A.Y., Luk K.D., and Kung A.W. Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women. Calcif Tissue Int 74 6 (2004 Jun) 516-521
42. Yamada Y., Miyauchi A., Goto J., Takagi Y., Okuizumi H., Kanematsu M., et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13 10 (1998 Oct) 1569-1576
43. Yamada Y. Association of a Leu(10)→Pro polymorphism of the transforming growth factor-beta1 with genetic susceptibility to osteoporosis and spinal osteoarthritis. Mech Ageing Dev 116 2-3 (2000 Jul 31) 113-123
44. Hinke V., Seck T., Clanget C., Scheidt-Nave C., Ziegler R., and Pfeilschifter J. Association of transforming growth factor-beta1 (TGFbeta1) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal German women. Calcif Tissue Int 69 6 (2001 Dec) 315-320
45. Janssens K., ten D.P., Ralston S.H., Bergmann C., and Van H.W. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278 9 (2003 Feb 28) 7718-7724
46. Campos-Xavier B., Saraiva J.M., Savarirayan R., Verloes A., Feingold J., Faivre L., et al. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum Genet 109 6 (2001 Dec) 653-658
47. Dequeker J., Aerssens J., and Luyten F.P. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res 15 5 (2003 Oct) 426-439
48. Hunter D.J., and Spector T.D. The role of bone metabolism in osteoarthritis. Curr Rheumatol Rep 5 1 (2003 Feb) 15-19
49. Kizawa H., Kou I., Iida A., Sudo A., Miyamoto Y., Fukuda A., et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 37 2 (2005 Feb) 138-144
50. Rodriguez-Lopez J., Pombo-Suarez M., Liz M., Gomez-Reino J.J., and Gonzalez A. Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians. Arthritis Res Ther 8 3 (2006 Mar 10) R55
51. Mustafa Z., Dowling B., Chapman K., Sinsheimer J.S., Carr A., and Loughlin J. Investigating the aspartic acid (D) repeat of asporin as a risk factor for osteoarthritis in a UK Caucasian population. Arthritis Rheum 52 11 (2005 Nov) 3502-3506
52. Jiang Q., Shi D., Yi L., Ikegawa S., Wang Y., Nakamura T., et al. Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese. J Hum Genet (2006 Sep 21)
53. Torres B., Orozco G., Garcia-Lozano J.R., Oliver J., Fernandez O., Gonzalez-Gay M.A., et al. Asporin repeat polymorphism in rheumatoid arthritis. Ann Rheum Dis (2006 May 17)
54. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359 6397 (1992 Oct 22) 693-699
55. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90 2 (1993 Jan 15) 770-774
56. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124 13 (1997 Jul) 2659-2670
57. Urness L.D., Sorensen L.K., and Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26 3 (2000 Nov) 328-331
58. Larsson J., Goumans M.J., Sjostrand L.J., van Rooijen M.A., Ward D., Leveen P., et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 20 7 (2001 Apr 2) 1663-1673
59. Nomura M., and Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393 6687 (1998 Jun 25) 786-790
60. Yang X., Li C., Xu X., and Deng C. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A 95 7 (1998 Mar 31) 3667-3672
61. Yang X., Chen L., Xu X., Li C., Huang C., and Deng C.X. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153 1 (2001 Apr 2) 35-46
62. Serra R., Johnson M., Filvaroff E.H., Laborde J., Sheehan D.M., Derynck R., et al. Expression of a truncated, kinase defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139 2 (1997) 541-552
63. Boumediene K., Conrozier T., Mathieu P., Richard M., Marcelli C., Vignon E., et al. Decrease of cartilage transforming growth factor-beta receptor II expression in the rabbit experimental steoarthritis-potential role in cartilage breakdown. Osteoarthritis Cartilage 6 2 (1998) 146-149
64. Verdier M.P., Seite S., Guntzer K., Pujol J.P., and Boumediene K. Immunohistochemical analysis of transforming growth factor beta isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads. Rheumatol Int 25 2 (2005 Mar) 118-124
65. Dabovic B., Chen Y., Colarossi C., Zambuto L., Obata H., and Rifkin D.B. Bone defects in latent TGF-beta binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-beta presentation. J Endocrinol 175 1 (2002 Oct) 129-141
66. Dabovic B., Chen Y., Colarossi C., Obata H., Zambuto L., Perle M.A., et al. Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability. J Cell Biol 156 2 (2002 Jan 21) 227-232
67. Darling E.M., and Athanasiou K.A. Growth factor impact on articular cartilage subpopulations. Cell Tissue Res 322 3 (2005 Dec) 463-473
68. van Beuningen H.M., van der Kraan P.M., Arntz O.J., and van den Berg W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71 2 (1994 Aug) 279-290
69. Hui W., Rowan A.D., and Cawston T. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine 16 1 (2001 Oct 7) 31-35
70. Hardingham T.E., Bayliss M.T., Rayan V., and Noble D.P. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheumatol 31 Suppl 1 (1992) 1-6
71. Zanni M., Tamburro A., and Rotilio D. IL-1 beta and TGF-beta 1 modulate the sulphation grade of chondro-disaccharides in porcine articular cartilage: a capillary electrophoresis study. J Lipid Mediat Cell Signal 12 1 (1995 Jul) 29-44
72. Bodo M., Carinci P., Baroni T., Bellucci C., Giammarioli M., Pezzetti F., et al. Role of growth factors on extracellular matrix production by chick embryo fibroblasts in vitro. Antagonist effect of TGF-beta through the control of IL-1 and IL-1Ra secretion. Cytokine 10 5 (1998 May) 353-360
73. Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints. Lab Invest 78 (1998) 133-142
74. Pronost S., Segond N., Macro M., Redini F., Penfornis H., Jullienne A., et al. Modulation of interleukin-1 receptor expression by transforming growth factor-beta in cultured rabbit articular chondrocytes: analysis by reverse transcription-polymerase chain reaction. Osteoarthritis Cartilage 3 3 (1995 Sep) 147-155
75. Pelletier J.P., Roughley P.J., DiBattista J.A., McCollum R., and Martel-Pelletier J. Are cytokines involved in osteoarthritic pathophysiology?. Semin Arthritis Rheum 20 6 Suppl 2 (1991 Jun) 12-25
76. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., and van den Berg W.B. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8 1 (2000 Jan) 25-33
77. Grimoud E., Heymann D., and Redini F. Recent advances in TGF-β effects on chondrocyte metabolism potential potential therapeutic roles of TGF-β in cartilage disorders. Cytokine Growth Factor Rev 13 (2002) 241-257
78. Branton M.H., and Kopp J.B. TGF-beta and fibrosis. Microbes Infect 1 15 (1999 Dec) 1349-1365
79. Bakker A.C., van de Loo F.A.J., van Beuningen H.M., Sime P., van Lent P.L.E.M., van der Kraan P.M., et al. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 9 (2002) 128-136
80. Scharstuhl A., Glansbeek H.L., van Beuningen H.M., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 169 1 (2002 Jul 1) 507-514
81. Scharstuhl A., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 48 12 (2003 Dec) 3442-3451
82. Blaney Davidson E.N., Vitters E.L., van den Berg W.B., and van der Kraan P.M. TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res Ther 8 3 (2006) R65
83. Roestenberg P., van Nieuwenhoven F.A., Joles J.A., Trischberger C., Martens P.P., Oliver N., et al. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol (2005 Dec 27)
84. Bonniaud P., Margetts P.J., Kolb M., Haberberger T., Kelly M., Robertson J., et al. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med 168 7 (2003 Oct 1) 770-778
85. Bonniaud P., Martin G., Margetts P.J., Ask K., Robertson J., Gauldie J., et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol 31 5 (2004 Nov) 510-516
86. Dammeier J., Brauchle M., Falk W., Grotendorst G.R., and Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease?. Int J Biochem Cell Biol 30 8 (1998 Aug) 909-922
87. Leask A., Sa S., Holmes A., Shiwen X., Black C.M., and Abraham D.J. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54 3 (2001 Jun) 180-183
88. Matsui Y., and Sadoshima J. Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol 37 2 (2004 Aug) 477-481
89. Paradis V., Dargere D., Vidaud M., De Gouville A.C., Huet S., Martinez V., et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30 4 (1999 Oct) 968-976
90. Shi-wen X., Pennington D., Holmes A., Leask A., Bradham D., Beauchamp J.R., et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 259 1 (2000 Aug 25) 213-224
91. Blaney Davidson E.N., Vitters E.L., Mooren F.M., Oliver N., Berg W.B., and van der Kraan P.M. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum 54 5 (2006 May) 1653-1661
92. Wahab N.A., Weston B.S., and Mason R.M. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. Exp Cell Res 307 2 (2005 Jul 15) 305-314
93. Mori T., Kawara S., Shinozaki M., Hayashi N., Kakinuma T., Igarashi A., et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 181 1 (1999 Oct) 153-159
94. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130 12 (2003 Jun) 2779-2791
95. Kadota H., Nakanishi T., Asaumi K., Yamaai T., Nakata E., Mitani S., et al. Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24/CCN2) during distraction osteogenesis. J Bone Miner Metab 22 4 (2004) 293-302
96. Luo Q., Kang Q., Si W., Jiang W., Park J.K., Peng Y., et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279 53 (2004 Dec 31) 55958-55968
97. Safadi F.F., Xu J., Smock S.L., Kanaan R.A., Selim A.H., Odgren P.R., et al. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 196 1 (2003 Jul) 51-62
98. Takigawa M., Nakanishi T., Kubota S., and Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 194 3 (2003 Mar) 256-266
99. Yamamoto Y., Furukawa K., Ueyama K., Nakanishi T., Takigawa M., and Harata S. Possible roles of CTGF/Hcs24 in the initiation and development of ossification of the posterior longitudinal ligament. Spine 27 17 (2002 Sep 1) 1852-1857
100. Li T.F., Darowish M., Zuscik M.J., Chen D., Schwarz E.M., Rosier R.N., et al. Smad3-deficient chondrocytes have enhanced bmp signaling and accelerated differentiation. J Bone Miner Res 21 1 (2006 Jan) 4-16
101. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., and van den Berg W.B. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 6 5 (1998) 306-317